Feijing Wu

Feijing Wu

Auto-generated profile, based on publicly available information

Feijing Wu

Columbia University Medical Center 1 Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Department of Medicine New York, NY

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2024 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
HKHiroki Kobayashi
Hiroki Kobayashi
TITadashi IIDA
Tadashi IIDA
YOYosuke Ochiai
Yosuke Ochiai
EMErmanno Malagola
Ermanno Malagola
XZXiaofei Zhi
Xiaofei Zhi
TWTimothy Wang
Timothy Wang
Cancer-associated fibroblasts (CAF) and nerves, components of the tumor microenvironment, have each been shown to directly promote gastrointestinal cancers. However, it remains unknown whether these cells interact with each other to regulate cancer progression. We found that in colorectal cancer, norepinephrine induces ADRB2 (β2-adrenergic receptor)–dependent nerve growth factor (NGF) secretion from CAFs, which in turn increases intratumor sympathetic innervation and norepinephrine accumulation. Adrenergic stimulation accelerates colorectal cancer growth through ADRA2A/Gi-mediated activation of Yes-associated protein (YAP). NGF from CAFs directly enhances colorectal cancer cell growth via the phosphatidylinositol-3-kinase/AKT pathway. Treatment with a tropomyosin receptor kinase (TRK) inhibitor decreased YAP and AKT activation and colorectal cancer progression in mice. In human colorectal cancer, high NGF expression is associated with mesenchymal-like tumor subtype and poor patient survival. These findings suggest a central role for reciprocal CAF–nerve cross-talk in promoting colorectal cancer progression. Blocking this feedforward loop with a TRK inhibitor may represent a potential therapeutic approach for colorectal cancer. Significance: Our work demonstrates that the bidirectional interplay between sympathetic nerves and NGF-expressing CAFs drives colorectal tumorigenesis. This study also offers novel mechanistic insights into catecholamine action in colorectal cancer. Inhibiting the neuro-mesenchymal interaction by TRK blockade could be a potential strategy for treating colorectal cancer.

31 December 2025 in Cancer Research
Verified
Journal Article
Closed access
HKHiroki Kobayashi
Hiroki Kobayashi
YOYosuke Ochiai
Yosuke Ochiai
Junya AraiJunya Arai
Junya Arai
MHMasahiro Hata
Masahiro Hata
FWFeijing Wu
Feijing Wu
TWTimothy Wang
Timothy Wang
Nerves can regulate tumorigenesis and cancer progression. However, clarification of the role of axon guidance molecules in tumorigenesis, innervation, and metastasis is required to better understand the tumor-promoting functions of nerves. Using murine KrasG12D-mutant pancreatic organoids, we screened axon guidance molecules and identified netrin-1 upregulation. Netrin-1 was also upregulated in vivo during pancreatic tumorigenesis in humans and mice. Mutant KRAS and β-adrenergic signaling upregulated netrin-1 and its receptor NEO1 in epithelial cells in part through the MAPK pathway. Ex vivo culture of celiac ganglia showed that netrin-1 promoted the axonogenesis of sympathetic neurons through nerve NEO1. In the Pdx1-Cre;LSL-KrasG12D/+ model, knockout (KO) of Ntn1, which encodes netrin-1, decreased sympathetic innervation and the development of pancreatic intraepithelial neoplasia. Treatment of pancreatic tumor organoids with recombinant netrin-1 enhanced cell growth, epithelial–mesenchymal transition (EMT), and cancer stemness with the upregulation of ZEB1 and SOX9 through NEO1-mediated activation of focal adhesion kinase (FAK). In Pdx1-Cre;LSL-KrasG12D/+;LSL-Trp53R172H/+ mice, Ntn1 KO reduced innervation, FAK phosphorylation, and the features of EMT and stemness to extend mouse survival. In a liver metastasis model of pancreatic ductal adenocarcinoma (PDAC), treatment with a netrin-1–neutralizing antibody or tumoral KO of Neo1 reduced ZEB1 and SOX9 and decreased tumor progression. In contrast, netrin-1 overexpression promoted innervation and the progression of PDAC liver metastasis. These data suggest that the netrin-1/NEO1 axis is a key regulator of PDAC progression, directly influencing cancer cell stemness and EMT while indirectly promoting tumor growth through nerves. Inhibiting the netrin-1 pathway could represent a potential therapeutic approach for PDAC. Significance: Netrin-1 promotes pancreatic tumorigenesis and metastasis directly and indirectly through nerves, highlighting the importance of tumor cell-nerve cross-talk in cancer and the potential of netrin-1 blockade as a treatment strategy.

11 July 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
QWQuin T. Waterbury
Quin T. Waterbury
JQJin Qian
Jin Qian
HZHualong Zheng
Hualong Zheng
ADAmanda Dirnberger
Amanda Dirnberger
OOOakley C. Olson
Oakley C. Olson
TWTimothy Wang
Timothy Wang
The bone marrow (BM) is altered in obesity to promote myeloid cell generation, but the mechanisms driving these changes remain unclear. Here, we show that obesogenic stimuli promote adipose tissue macrophages to recruit neutrophils from the BM in mice. Recruitment of BM neutrophils activates hematopoietic stem cells, which produce myeloid cells that accumulate in the circulation and drive inflammation. This recruitment is not resolved by weight loss, leading to sustained myelopoiesis in previously obese mice. Inhibiting neutrophil recruitment out of the BM in obese mice or during weight loss reduces BM myelopoiesis and adipose tissue inflammation, and improves glucose tolerance. In humans with obesity, plasma neutrophil chemokines are increased, correlate with increased insulin resistance, but do not decrease with weight loss. Our results demonstrate that neutrophil recruitment is a key mediator of myelopoiesis during obesity, and targeting this pathway is a potential strategy to improve inflammation during obesity and weight loss.

3 February 2023 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
SCSijun Chen
Sijun Chen
FWFeijing Wu
Feijing Wu
JZJiaxuan Zhang
Jiaxuan Zhang
JZJian wei Zhu
Jian wei Zhu
XZXIAORONG ZHOU
XIAORONG ZHOU
XZXiaofei Zhi
Xiaofei Zhi
Background. Gastrointestinal stromal tumor (GIST) originates from a pacemaker cell, the Cajal cell. However, little is known about the cancer neuroscience in GIST. In this study, we aimed to elucidate the clinical and biological roles of adrenoceptor beta 2 (ADRB2) in GIST. Methods. Immunohistochemistry was used to evaluate the expression of ADRB2 in GIST tissues. The biological effects of ADRB2 on GIST cell proliferation, migration, invasion, and apoptosis were explored using Cell Counting Kit 8, plate colony formation assay, transwell invasion assay, and flow cytometry. We also explored the growth and metastasis of xenograft tumors in nude mice. Western blotting was used to quantify protein expression and phosphorylation. Results. ADRB2 is generally highly expressed in GIST. High ADRB2 expression was significantly associated with risk level, tumor size, mitotic count, and metastasis. Overexpression of ADRB2 promoted GIST cell proliferation, migration, invasion, and apoptosis, while silencing ADRB2 expression showed the opposite effects. Furthermore, we found that silencing endogenous ADRB2 inhibited GIST progression and metastasis in nude mice. ADRB2-induced ETV1 upregulation enhanced the activation of c-KIT. Conclusion. ADRB2 plays an important role in the proliferation and metastasis of GIST and is expected to be a potential target for the treatment of GIST.

17 June 2026
Verified
Other
Open access
PDF file
HKHiroki Kobayashi
Hiroki Kobayashi
YOYosuke Ochiai
Yosuke Ochiai
Junya AraiJunya Arai
Junya Arai
MHMasahiro Hata
Masahiro Hata
FWFeijing Wu
Feijing Wu
TWTimothy Wang
Timothy Wang
Figure S5 shows that β-adrenergic stimulation increases mT4 PDAC cell growth and migration while upregulating stemness- and EMT-related genes.

17 June 2026
Verified
Other
Open access
PDF file
HKHiroki Kobayashi
Hiroki Kobayashi
YOYosuke Ochiai
Yosuke Ochiai
Junya AraiJunya Arai
Junya Arai
MHMasahiro Hata
Masahiro Hata
FWFeijing Wu
Feijing Wu
TWTimothy Wang
Timothy Wang
Figure S6 shows that Ntn1 knockout decreases innervation, reduces CD11b+ myeloid cells, and increases CD8+ T cells in KPC tumors.